{{Rsnum
|rsid=7167936
|Gene=CYP19A1
|Chromosome=15
|position=51207348
|Orientation=plus
|GMAF=0.4114
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 18.6 | 47.8 | 33.6
| HCB | 20.4 | 53.3 | 26.3
| JPT | 28.3 | 49.6 | 22.1
| YRI | 68.0 | 30.6 | 1.4
| ASW | 66.7 | 26.3 | 7.0
| CHB | 20.4 | 53.3 | 26.3
| CHD | 22.0 | 49.5 | 28.4
| GIH | 39.6 | 46.5 | 13.9
| LWK | 57.3 | 39.1 | 3.6
| MEX | 37.9 | 50.0 | 12.1
| MKK | 33.3 | 50.6 | 16.0
| TSI | 30.4 | 41.2 | 28.4
| HapMapRevision=28
}}{{PMID Auto
|PMID=20960227
|Title=Genetic variation in the androgen estrogen conversion pathway in relation to breast cancer prognosticators
}}

{{on chip | Illumina Human 1M}}